Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia

Published:2024-04-24 Issue:1 Volume:14 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Wang Cheng,Li Jianfeng^ORCID,Liu Weiyang,Zhao Lingling,Yan Han,Yan Yuchen,Ren Jiayi,Peng Lijun,Zhang Jiaojiao,Liu Yuanfang,Weng Xiangqin,Zhu Yongmei^ORCID,Jing Duohui^ORCID,Mi Jian-Qing^ORCID,Wang Jin^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41408-024-01055-1.pdf

Reference15 articles.

1. Stanulla M, Dagdan E, Zaliova M, Möricke A, Palmi C, Cazzaniga G, et al. IKZF1plus defines a new minimal residual disease–dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36:1240–9.

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology acute lymphoblastic leukemia. https://www.nccn.org/professionals/physician_gls/pdf/all.pdf.

3. Ribera JM, Garcia O, Montesinos P, Brunet S, Abella E, Barrios M, et al. Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation. Br J Haematol. 2012;159:78–81.

4. Chalandon Y, Thomas X, Hayette S, Cayuela JM, Abbal C, Huguet F, et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125:3711–9.

5. Li JF, Dai YT, Lilljebjorn H, Shen SH, Cui BW, Bai L, et al. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci USA. 2018;115:E11711–20.